GeneDx Holdings (WGS) Other Non Operating Income (2020 - 2026)

GeneDx Holdings (WGS) has reported Other Non Operating Income for 7 consecutive years, with $162000.0 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Other Non Operating Income fell 32.22% year-over-year to $162000.0 in Q2 2026; TTM through Jun 2026 was -$11.2 million, a 1371.98% decrease from a year earlier, with the FY2025 full-year figure at -$4.3 million, up 66.83% from the prior year.
• Other Non Operating Income was $162000.0 for Q2 2026 at GeneDx Holdings, up from -$6.6 million in the prior quarter.
• Over five years, Other Non Operating Income peaked at $2.7 million in Q1 2023 and troughed at -$13.5 million in Q2 2024.
• A 5-year average of -$1.3 million and a median of $2000.0 in 2022 frame the typical range for Other Non Operating Income.
• Across the five-year window, Other Non Operating Income plunged 56800.0% in 2023 and surged 464.86% in 2025, its largest moves.
• Over 5 years, Other Non Operating Income stood at -$1000.0 in 2022, then slumped by 4800.0% to -$49000.0 in 2023, then slumped by 1357.14% to -$714000.0 in 2024, then slumped by 543.0% to -$4.6 million in 2025, then soared by 103.53% to $162000.0 in 2026.
• The last three Other Non Operating Income figures came in at $162000.0 (Q2 2026), -$6.6 million (Q1 2026), and -$4.6 million (Q4 2025), per Business Quant data.